RE:RE:LENDEN POSTS INSIDER BOUGHT SHARES ON OPEN MARKETHi GV. I'm sure I am missing your point.
I thought this is old news or did this lady receive or purchase a large number of shares. If so it certainly is a vote of confidence for the science.
Also, while the share price is easing down it is still 66% above early September. That share build up in price and volume plus the rescheduled AGMs sure leads me to speculate.
On the Zenith side with zen3694 on mCRPC trial while 4 months into dosing we have not seen any results and I would guess it is too early at this stage.
On the RVX side rvx-208 passed that safety test which is obviously great news but we won't have anything concrete until the futility analysis in 2017.
I can't remember hearing any results from the other trials or things like FDA approvals.
One thing for sure there are lots of things happening.
GLTA
Toinv